Aquestive Therapeutics Inc
AQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$578.4M
Close$
$-1.77
136.8% downside
Current Fair Value
136.8% downsideOvervalued by 136.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $578.40 Million |
|---|---|
| Enterprise Value | $540.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 1.47 |
| Outstanding Shares | 124,994,165 |
Return
| Return on Equity | 138.24% |
|---|---|
| Return on Assets | -59.22% |
| Return on Invested Capital | -57.65% |
Valuation & Multiples
| P/E Ratio | -7.09 |
|---|---|
| PEG | -10.31 |
| Price to Sales | - |
| Price to Book Ratio | -4.82 |
| Enterprise Value to Revenue | 9.98 |
| Enterprise Value to EBIT | -8.1 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -1.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.42 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2855▼ 5.97% |
|---|---|
| Total Calls | 1,382,848▲ 2.34% |
| Total Puts | 394,800▼ 15.35% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 57.86%▼ 0.88% |
|---|---|
| Total Invested | $300.83M▼ 3.79% |
| Investors Holding | 195▲ 8.00% |
ESG Score
No data